CA
NZ
UK
AU
IND
US
…
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Publicly available information on EUDA Health Holdings Limited (NASDAQ: EUDA) is limited; filings describe it as a healthcare company but provide few operational details. Long-term growth would depend on expansion of healthcare services in its markets and successful execution of management's strategy, and investors may find potential upside if the company demonstrates consistent revenue growth and improved disclosure.
Key material risks include limited disclosure and transparency, uncertain or unreleased financial performance, execution and regulatory risks in its operating jurisdictions, and low trading liquidity.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -2.73M | -17.64M | -8.43M | -24.93M | 0.95M |
| Minority interest | -0.01M | 0.03M | -0.00M | 0.07M | -0.04M |
| Net income | -2.77M | -15.36M | -10.04M | -24.88M | 0.86M |
| Selling general administrative | 4.15M | 3.21M | 4.27M | 7.15M | 4.08M |
| Selling and marketing expenses | 1.28M | 0.13M | 0.53M | 1.90M | 1.26M |
| Gross profit | 2.99M | 0.76M | 0.84M | 3.35M | 4.24M |
| Reconciled depreciation | 0.41M | 0.17M | 0.12M | 0.26M | 0.26M |
| Ebit | -2.50M | -17.60M | -8.41M | -18.50M | -1.23M |
| Ebitda | -2.09M | -17.42M | -8.30M | -18.25M | -0.58M |
| Depreciation and amortization | 0.41M | 0.17M | 0.11M | 0.26M | 0.65M |
| Operating income | -2.44M | -17.34M | -3.96M | -12.06M | -1.23M |
| Other operating expenses | 9.26M | 21.35M | 7.67M | 15.56M | 11.77M |
| Interest expense | 0.23M | 0.04M | 0.02M | 0.12M | 0.13M |
| Tax provision | 0.04M | -0.00M | 0.00M | 0.02M | 0.05M |
| Net interest income | -0.23M | -0.04M | -0.02M | -0.12M | -0.13M |
| Income tax expense | 0.04M | -0.00M | 1.60M | 0.02M | 0.05M |
| Total revenue | 6.82M | 4.01M | 3.71M | 9.84M | 10.54M |
| Total operating expenses | 5.43M | 18.10M | 4.80M | 9.07M | 5.47M |
| Cost of revenue | 3.83M | 3.25M | 2.86M | 6.49M | 6.30M |
| Total other income expense net | -0.29M | -0.31M | -4.47M | -19.09M | 2.18M |
| Net income from continuing ops | -2.77M | -17.64M | -8.43M | -24.95M | 0.90M |
| Net income applicable to common shares | - | - | - | -24.88M | 0.86M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1.72M | 1.73M | 1.31M | 25.63M | 8.00M |
| Intangible assets | 0.16M | 0.34M | - | - | 0.29M |
| Other current assets | 0.36M | 0.23M | 0.30M | 0.22M | 0.07M |
| Total liab | 5.98M | 4.30M | 8.79M | 29.14M | 7.40M |
| Total stockholder equity | -4.25M | -2.55M | -7.50M | -3.52M | 0.52M |
| Other current liab | 2.88M | 2.42M | 5.21M | 27.32M | 4.07M |
| Common stock | 48.83M | 47.81M | 27.43M | 21.31M | 0.33M |
| Capital stock | 48.83M | 47.81M | 27.43M | 21.31M | 0.33M |
| Retained earnings | -52.87M | -50.10M | -34.74M | -24.70M | 0.18M |
| Other liab | - | - | - | - | 0.05M |
| Good will | - | - | - | 0.00M | 0.99M |
| Other assets | - | - | - | 0.46M | 2.20M |
| Cash | 0.35M | 0.24M | 0.19M | 0.14M | 0.19M |
| Total current liabilities | 5.84M | 4.14M | 8.72M | 29.12M | 7.32M |
| Current deferred revenue | 0.52M | 0.48M | 0.21M | -3.69M | - |
| Net debt | 2.06M | 1.03M | 3.19M | 3.74M | 0.27M |
| Short term debt | 2.33M | 1.22M | 3.30M | 3.86M | 0.43M |
| Short long term debt | 2.20M | 1.04M | 3.17M | 3.78M | 0.35M |
| Short long term debt total | 2.40M | 1.27M | 3.37M | 3.88M | 0.46M |
| Other stockholder equity | - | -0.00M | - | 3.27M | -0.52M |
| Property plant equipment | - | - | - | 0.12M | 0.16M |
| Total current assets | 1.04M | 0.76M | 0.72M | 25.03M | 4.35M |
| Net tangible assets | - | - | - | -3.52M | -0.76M |
| Net receivables | 0.33M | 0.17M | 0.24M | 24.01M | 4.09M |
| Inventory | 0.00M | 0.13M | - | 0.65M | - |
| Accounts payable | 0.01M | 0.03M | 0.00M | 1.64M | 2.82M |
| Accumulated other comprehensive income | -0.21M | -0.26M | -0.19M | -0.13M | 0.01M |
| Non currrent assets other | 0.18M | 0.28M | 0.38M | -0.12M | 2.20M |
| Non current assets total | 0.68M | 0.97M | 0.59M | 0.60M | 3.65M |
| Capital lease obligations | 0.20M | 0.23M | 0.20M | 0.10M | 0.11M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.15M | 0.00M | -0.27M | -0.36M |
| Change to liabilities | - | - | - | -1.13M | 1.38M |
| Total cashflows from investing activities | -0.10M | -0.15M | - | -0.27M | -0.36M |
| Net borrowings | 2.22M | 2.16M | 1.44M | -0.01M | -0.30M |
| Total cash from financing activities | 2.55M | 2.32M | 2.35M | 2.49M | -0.17M |
| Change to operating activities | - | - | - | 2.54M | -0.04M |
| Net income | -2.77M | -17.60M | -8.44M | -24.95M | 0.90M |
| Change in cash | 0.11M | 0.04M | -0.59M | 0.59M | -0.06M |
| Begin period cash flow | 0.24M | 0.20M | 0.78M | 0.19M | 0.25M |
| End period cash flow | 0.35M | 0.24M | 0.20M | 0.78M | 0.19M |
| Total cash from operating activities | -2.43M | -2.03M | -2.92M | -1.53M | 0.44M |
| Issuance of capital stock | 0.00M | 0.05M | 0.79M | 1.82M | - |
| Depreciation | 0.41M | 0.17M | 0.12M | 0.26M | 0.26M |
| Other cashflows from investing activities | -0.03M | -0.05M | 0.00M | - | - |
| Change to inventory | 0.05M | -0.13M | 0.00M | 3.69M | - |
| Change to account receivables | -0.17M | 0.08M | -0.03M | -0.17M | -0.26M |
| Other cashflows from financing activities | 0.23M | 0.12M | 0.12M | 0.75M | 0.22M |
| Change to netincome | - | - | - | 21.98M | -1.87M |
| Capital expenditures | 0.10M | 0.12M | 0.00M | 0.02M | 0.00M |
| Change in working capital | -0.23M | 0.19M | 0.53M | 1.12M | 1.18M |
| Stock based compensation | - | - | - | 0.22M | - |
| Other non cash items | 0.16M | 15.21M | 4.87M | 21.87M | -1.87M |
| Free cash flow | -2.53M | -2.15M | -2.92M | -1.54M | 0.44M |
Sector: Real Estate Industry: Real Estate Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| EUDA EUDA Health Holdings Limited |
-1.31 8.84% |
13.51 | - | 7.81 | 7.44 | - | 7.57 | -25.90 |
| CBRE CBRE Group Inc Class A |
-0.84 0.62% |
135.51 | 38.92 | 21.37 | 1.09 | 4.95 | 1.28 | 25.73 |
| BEKE Ke Holdings Inc |
0.03 0.16% |
18.85 | 42.90 | 16.92 | 0.33 | 2.33 | 1.66 | 24.07 |
| VNNVF Vonovia SE |
- -% |
18.44 | - | 13.44 | 3.96 | 0.83 | 4.07 | -3.05 |
| VTAGY Vantage Towers AG |
- -% |
21.42 | 42.00 | 37.59 | 28.32 | 3.61 | 21.19 | 24.26 |
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
| Name | Title | Year Born |
|---|---|---|
| Dr. Wei Wen Chen | CEO & Director | 1984 |
| Ms. Jenifer Goh | Pres of Operations | 1990 |
| Mr. Steven John Sobak | Chief Financial Officer | 1946 |
| Mr. Daniel Tan | Chief Technology Officer | 1981 |
| Dr. Wei Wen Chen | CEO & Director | 1985 |
| Ms. Jenifer Goh | President of Operations | 1990 |
| Mr. Alfred Lim | Executive Director | 1952 |
| Mr. Daniel Tan | Chief Technology Officer | 1982 |
| Mr. Alfred Lim | CEO & Executive Director | 1952 |
| Ms. Whye Shin Tay | Interim Chief Financial Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...